Compagnie Lombard Odier SCmA’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.59M Hold
12,565
0.07% 96
2025
Q1
$6.09M Buy
12,565
+3,000
+31% +$1.45M 0.07% 102
2024
Q4
$3.85M Sell
9,565
-864
-8% -$348K 0.06% 103
2024
Q3
$4.85M Buy
10,429
+3,200
+44% +$1.49M 0.08% 97
2024
Q2
$3.39M Buy
7,229
+2,929
+68% +$1.37M 0.06% 107
2024
Q1
$1.8M Buy
4,300
+3,000
+231% +$1.25M 0.03% 137
2023
Q4
$529K Hold
1,300
0.01% 216
2023
Q3
$452K Sell
1,300
-600
-32% -$209K 0.01% 194
2023
Q2
$669K Hold
1,900
0.02% 158
2023
Q1
$599K Sell
1,900
-3,614
-66% -$1.14M 0.02% 186
2022
Q4
$1.59M Buy
5,514
+4,214
+324% +$1.22M 0.04% 139
2022
Q3
$376K Sell
1,300
-330
-20% -$95.4K 0.01% 237
2022
Q2
$460K Hold
1,630
0.01% 209
2022
Q1
$425K Hold
1,630
0.01% 229
2021
Q4
$358K Buy
1,630
+1,250
+329% +$275K 0.01% 283
2021
Q3
$69K Hold
380
﹤0.01% 466
2021
Q2
$76K Buy
380
+130
+52% +$26K ﹤0.01% 440
2021
Q1
$54K Buy
+250
New +$54K ﹤0.01% 497
2020
Q3
Sell
-325
Closed -$94K 581
2020
Q2
$94K Buy
325
+75
+30% +$21.7K ﹤0.01% 322
2020
Q1
$59K Buy
+250
New +$59K ﹤0.01% 339
2019
Q1
Sell
-300
Closed -$50K 596
2018
Q4
$50K Sell
300
-200
-40% -$33.3K ﹤0.01% 383
2018
Q3
$96K Hold
500
﹤0.01% 352
2018
Q2
$85K Buy
+500
New +$85K ﹤0.01% 374
2015
Q2
Sell
-537
Closed -$63K 939
2015
Q1
$63K Buy
+537
New +$63K ﹤0.01% 760
2014
Q4
Sell
-1,818
Closed -$204K 863
2014
Q3
$204K Sell
1,818
-4,371
-71% -$490K 0.01% 501
2014
Q2
$586K Buy
6,189
+2,506
+68% +$237K 0.02% 288
2014
Q1
$261K Buy
3,683
+1,357
+58% +$96.2K 0.01% 452
2013
Q4
$173K Buy
+2,326
New +$173K 0.01% 559